The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2019 | VIOLET: VATS vs. open lobectomy for lung cancer
The VIOLET study (ISRCTN13472721) is a large, multicenter, randomized trial investigating video-assisted thoracoscopic surgery (VATS) vs. open lobectomy for lung cancer. We spoke to Eric Lim, MD, of the Royal Brompton & Harefield NHS Foundation Trust, London, UK, about the trial at the British Thoracic Oncology Group (BTOG) 2019 Annual Conference in Dublin, Ireland. Prof. Lim highlights the importance of comparing keyhole and open surgery in this setting, and explains how the surgeon’s themselves will perform 50% of the operations with each method.
